Carl Zeiss Meditec AG

XETRA:AFX.DE

Sector

🏥 Health Care

Industries

🩺 Medical Instruments

🔬 Clinical Trials

🕶 Eyewear

🏥 Hospitals & Clinics

💻 Telehealth

Location

Germany

Market Cap

USD 5.53 B

Share Price

USD 63.19

Avg Daily Volume

178,163

Change (1 day)

-5.29%

Change (1 year)

-10.60%

Change (YTD)

33.41%

Carl Zeiss Meditec AG Depreciation And Amortization for the year ending September 30, 2024: USD 147.83 M

Carl Zeiss Meditec AG Depreciation And Amortization is USD 147.83 M for the year ending September 30, 2024, a 88.77% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.

Carl Zeiss Meditec AG Depreciation And Amortization for the year ending September 30, 2023 was USD 78.31 M, a 14.53% change year over year.
Carl Zeiss Meditec AG Depreciation And Amortization for the year ending September 30, 2022 was USD 68.38 M, a -4.08% change year over year.
Carl Zeiss Meditec AG Depreciation And Amortization for the year ending September 30, 2021 was USD 71.29 M, a 0.67% change year over year.
Carl Zeiss Meditec AG Depreciation And Amortization for the year ending September 30, 2020 was USD 70.81 M, a 34.34% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Depreciation And Amortization	Dividends Paid	Common Stock Issued	Common Stock Repurchased

XETRA: AFX.DE

Carl Zeiss Meditec AG

CEO	Dr. Markus Weber
IPO Date	March 22, 2000
Location	Germany
Headquarters	Goschwitzer Strasse 51-52
Employees	2,066
Sector	🏥 Health Care
Industries Medical Instruments 🔬 Clinical Trials 🕶 Eyewear 🏥 Hospitals & Clinics 💻 Telehealth

Description

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.